EVERTEC delivered a clean third-quarter beat. Adjusted earnings of $1.07 per share topped the $0.97 consensus and the $1.01 Earnings Whisper number by 5.9%. Revenue of $282.99 million beat the $273.68 million consensus by 3.4% and grew 23.8% year over year. Reported revenue growth has now climbed from 8% in the first quarter to 20% in the second and 24% in the third. Earnings Whispers puts year-over-year earnings growth at 11.5% on its normalized basis, while the company's own adjusted comparison shows 16% growth against $0.92. The central tension is that the headline acceleration is mostly built on acquisitions, buybacks, and currency. Management's preliminary look at 2027 points to organic headwinds that its marquee new contract will not offset until late in the year.

The quality of the beat deserves scrutiny. Latin America revenue jumped 59%, or 52% in constant currency, on contributions from Demensa and Tecnobank. Organic growth in the region was a solid but far more modest low double digits. Currency added about $6 million, and constant-currency growth was 21%.

Adjusted EBITDA rose 19% to $110.5 million, but the consolidated margin slipped to 39.0% from 40.5% as the lower-margin Latin American business became a bigger part of the mix. Adjusted net income grew only about 8%, held back by:

• higher interest expense;
• higher operating depreciation and amortization;
• a larger non-controlling interest tied to Tecnobank.

The per-share figure looks better largely because diluted shares fell to 60.4 million from 64.8 million after aggressive repurchases. EVERTEC spent $82.5 million on buybacks year to date and raised its authorization to $150 million.

GAAP earnings fell to $0.49 from $0.51 per share. The prior-year quarter included a $6 million R&D tax-credit gain, and this year brought higher interest and tax costs.

Beneath the consolidated numbers, segment execution was genuinely good. Management cited margin expansion in three segments:

• Merchant Acquiring margins widened 220 basis points to 42%.
• Payments Puerto Rico & Caribbean margins rose 280 basis points to 57%, helped by POS transactions and ATH Business growth.
• Latin America margins improved 310 basis points to 30.1%.

The outlooks for Merchant Acquiring and Payments were raised to high-single-digit growth from mid-single digits. The weak spot remains Business Solutions, where revenue fell 5% and segment EBITDA dropped 18% under the 10% Popular discount. That outlook was trimmed on delayed new business wins. The Popular discount was fully lapped in October, which removes a year-over-year drag starting in the fourth quarter.

The guidance raise is less dramatic than the headline suggests. Full-year revenue is now expected at $1.088 billion to $1.096 billion, implying 16.7% to 17.6% growth versus 16.4% to 17.5% previously. Adjusted EPS guidance of $4.00 to $4.08 implies 10.5% to 12.7% growth. The prior range was 8.8% to 13.8%, so the update mostly narrows the range around a similar midpoint.

The call analysis compares the new targets with the first-quarter guide, which makes the progression look steeper. Measured against the latest prior outlook, the lift is incremental, consistent with a raise that landed in line with estimates. Part of the EPS support also comes from a lower adjusted tax rate guide of 10% to 11%, down from 11% to 12%. Meanwhile, margin guidance settled at roughly 39.5%, below the original 39.5% to 40.5% midpoint.

The forward story is a bridge, and bears have legitimate ammunition for 2027. Management flagged several headwinds for next year:

• an EBT contract renewal at lower pricing;
• lower GetNet volumes, only partly cushioned by contractual minimums;
• moderating ATH Mobile and merchant growth against tougher comparisons;
• one-time Puerto Rico fine amnesty benefits from the second and third quarters that will not recur.

The offsets come later. Transbank in Chile is now the largest contract after Popular, but it contributes late in the second half of 2027 and mostly in 2028. Demensa cost synergies become meaningful in 2027 and are fully realized in 2028.

The balance sheet is also more stretched. Leverage stands at 2.46x versus 1.81x a year ago, net debt is near $1 billion, and a credit facility renewal is pending. Leverage did improve sequentially from 2.55x. Brazil's political environment and real volatility add another layer of risk.

Investor sentiment heading into the report weakened, falling from -0.21 to -0.35, a meaningful but not extreme move further into negative territory. Price action has been more constructive. The stock set a 52-week high of $34.41 the day after the August report, then slid to $26.71 by September 30. It rebounded 22.5% from that low to $32.72 before this release, about 15% above its 200-day moving average but still 3.7% below the post-August open. The Earnings Whispers trend signals are mostly positive, reflecting that recovery, so the stock entered the print near the upper end of its range despite sour sentiment.

The bottom line is that EVERTEC delivered a convincing beat with accelerating reported growth and stronger segment margins. However, the drivers are largely acquisitions, buybacks, currency, and a lower tax rate, and the guidance increase is incremental rather than transformative. The investment case now rests on bridging a softer organic 2027 to the Transbank and synergy payoff in 2028 while managing elevated leverage. After a sharp rebound into the report, that is a more nuanced setup than the headline surprise implies.